Cellulite Treatment Market By Procedure Type (Non-invasive, Minimally Invasive, Topical), By Cellulite Type (Soft Cellulite, Hard Cellulite, Edematous), By End User (Hospitals, Clinics and Beauty Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global cellulite treatment market was valued at $2,140.0 million in 2021, and is projected to reach $5,729.06 million by 2031, registering a CAGR of 10.3% from 2022 to 2031.
Cellulite is the herniation of subcutaneous fat within fibrous connective tissue that manifests as skin dimpling and nodularity, often on the pelvic region (specifically the buttocks), lower limbs, and abdomen. The condition is most prevalent in women.
The increase in obesity rate owing to fast food consumption and sedentary lifestyle drive the growth of the market. Weight gain and high obesity are responsible for the development of cellulites. In addition, the increase in the number of cosmetic procedures and the rise in a number of cosmetic clinics contribute toward the growth of the market. For instance, according to International Society of Aesthetic Plastic Surgery (ISAPS) survey, in 2020 about 10,129,528 cosmetic surgical procedures are carried worldwide. The rise in demand for attractive physical appearance in men and women owing to social media influence and celebrities who are popular among the young generation, motivate them to look aesthetically appealing, which provides ample opportunities for market growth. The cellulite treatment, reduces the fat depositions especially from around the thighs and buttocks which further enhances the appearance.
The increase in demand for minimally invasive cosmetic procedures, rise in popularity of cosmetic procedures and genetical factors predominantly in women contribute toward the market growth. Increase in awareness about advanced non-invasive cellulite treatment, and surge in number of cosmetology surgeons are expected to drive the market growth in the coming years.
Moreover, the increase in R&D activities for development of advanced cellulite treatment, product approvals and novel product launch in the market by key players boost the market growth. For instance, in July 2020, Endo International plc, a highly-focused specialty branded and generics pharmaceutical company, has received U.S. Food and Drug Administration (FDA) approval for its, Qwo (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women. However, the high cost of advanced cellulite treatment and underdeveloped health care infrastructure in developing countries may hinder the growth of the market.
The cellulite treatment market is segmented on the basis of procedure type, cellulite type, end user and region. By procedure type, the market is divided into non-invasive, minimal invasive and topical. By cellulite type, the market is classified into soft cellulite, hard cellulite, and edematous cellulite. The soft cellulite segment is further divided into male and female. The hard cellulite segment is further bifurcated into male and female. By end user, the market is categorized into hospitals, clinics & beauty centers, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include ABBVIE, Bausch Health Companies Inc, Candela Syneron, Cynosure, Galderma SA, Johnson & Johnson, Merz Pharma GmbH & Co. KGaA, Sientra Inc, Sinclair Pharma and Teoxane Laboratories.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cellulite treatment market analysis from 2021 to 2031 to identify the prevailing cellulite treatment market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the cellulite treatment market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global cellulite treatment market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Procedure Type
Non-invasive
Minimally Invasive
Topical
By Cellulite Type
Soft Cellulite
Gender
Male
Female
Hard Cellulite
Gender
Male
Female
Edematous
By End User
Hospitals
Clinics and Beauty Centers
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest Of Europe
Asia-Pacific
Japan
China
Australia
India
Rest Of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest Of LAMEA
Key Market Players
Abbvie Inc
Candela Syneron
Cynosure Technologies
Merz Pharma GmbH & Co. KGaA
Bausch Health Companies Inc.
Hologic Inc
Zimmer Aesthetics
Galderma SA
Sinclair Pharmaceuticals Limited
Endo International plc
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook